S. Sreevatsan et al., MUTATIONS ASSOCIATED WITH PYRAZINAMIDE RESISTANCE IN PNCA OF MYCOBACTERIUM-TUBERCULOSIS COMPLEX ORGANISMS, Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 636-640
A gene (pncA) with mutations associated with pyrazinamide resistance i
n Mycobacterium tuberculosis complex members was characterized in 67 p
yrazinamide-resistant and 51 pyrazinamide-susceptible isolates recover
ed from diverse geographic localities and anatomic sites and typed by
IS6110 profiling, All pyrazinamide-susceptible organisms had identical
pncA alleles, In striking contrast, 72% of the 67 resistant organisms
had pncA mutations that altered the primary amino acid sequence of py
razinamidase. A total of 17 previously undescribed mutations were foun
d, including upstream mutations, missense changes, nucleotide insertio
ns and deletions, and termination mutations, The mutations were arraye
d along virtually the entire length of the gene, These data are furthe
r evidence that most drug resistance in M. tuberculosis is due to simp
le mutations occurring in chromosomally encoded genes rather than to a
cquisition of resistance genes by horizontal transfer events.